Proposes adding suffixes to distinguish biosimilar drug names
With increasingly expensive cancer drugs, what price should be paid for innovation?
Assessing the Darwinian model of mutation in pharmaceutical companies
Acquires cloud-based medical imaging firm Merge Healthcare
Former VP of Eli Lilly and AstraZeneca joins the company
Pleiotropy in biology has direct analogues in the life science business
How can pharma best get the digital/face-to-face mix right?
And Jeffrey Ubben resigns from the board
Follows app's 2012 debut in iPhone version
Anton Ussi on the institute's long-term plans
Excel Communications reflects on its development over the last three decades